Repeated clear benefits of immunotherapy in a patient with Charcot-Marie-Tooth disease carrying a rare point mutation in PMP22

被引：0

作者：

Kawai, Honami ^{[1
]}

Nishida, Yoichiro ^{[1
]}

Kanda, Takashi ^{[2
]}

Yokota, Takanori ^{[1
]}

机构：

[1] Inst Sci Tokyo, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan

[2] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi 7558505, Japan

来源：

NEUROGENETICS | 2025年 / 26卷 / 01期

关键词：

Charcot-Marie-Tooth disease (CMT); PMP22; Point mutation; Chronic inflammatory demyelinating polyneuropathy (CIDP); Optic neuritis;

D O I：

10.1007/s10048-025-00808-9

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

We describe a unique patient who had been diagnosed with inflammatory demyelinating polyneuropathy (CIDP) for 13 years with frequent clear responses to immunotherapies and was finally diagnosed with Charcot-Marie-Tooth disease (CMT) with a rare point mutation in PMP22 (c.320G > A, p.G107D). Some patients diagnosed with young-onset CIDP may have underlying CMT, and extensive genetic testing including point mutations of PMP22 gene is required not to miss the diagnosis.

引用

页数：4

共 50 条

[41] Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease
Koutsis, Georgios
Pandraud, Amelie
Polke, James M.
Wood, Nicholas W.
Panas, Marios
Karadima, Georgia
Houlden, Henry
BRAIN, 2012, 135
[42] Left ventricular hypertrabeculation/noncompaction with PMP22 duplication-based Charcot-Marie-Tooth disease type 1A
Corrado, Giovanni
Checcarelli, Nicoletta
Santarone, Mauro
Stoellberger, Claudia
Finsterer, Josef
CARDIOLOGY, 2006, 105 (03) : 142 - 145
[43] CRISPR/Cas9-mediated downregulation of PMP22 ameliorates Charcot-Marie-Tooth disease 1A in mice
Lee, J. Y.
Song, D. W.
Lee, J.
Bae, H.
Yu, H. S.
Lee, K. J.
Kim, H. K.
Hwang, H.
Kwak, G.
Kim, D.
Kim, S.
Hong, Y. B.
Lee, J. M.
Choi, B.
HUMAN GENE THERAPY, 2018, 29 (12) : A26 - A26
[44] THE MODIFYING EFFECT A PMP22 DELETION IN A FAMILY WITH CHARCOT-MARIE-TOOTH TYPE 1 NEUROPATHY DUE TO AN EGR2 MUTATION
Remenyi Viktoria
Inczedy-Farkas Gabriella
Gal Aniko
Bereznai Benjamin
Pal Zsuzsanna
Karcagi Veronika
Mechler Ferenc
Molnar Maria Judit
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2014, 67 (11-12): : 420 - 425
[45] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
van Paassen, Barbara W.
van der Kooi, Anneke J.
van Spaendonck-Zwarts, Karin Y.
Verhamme, Camiel
Baas, Frank
de Visser, Marianne
ORPHANET JOURNAL OF RARE DISEASES, 2014, 9
[46] Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
Nobbio, L
Vigo, T
Abbruzzese, M
Levi, G
Brancolini, C
Mantero, S
Grandis, M
Benedetti, L
Mancardi, G
Schenone, A
NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 263 - 273
[47] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies
Barbara W van Paassen
Anneke J van der Kooi
Karin Y van Spaendonck-Zwarts
Camiel Verhamme
Frank Baas
Marianne de Visser
Orphanet Journal of Rare Diseases, 9
[48] Genotype–phenotype correlation of Charcot-Marie-Tooth type 1E patients with PMP22 mutations
Jee Young Kim
Haesoo Koo
Kee-Duk Park
Sun Sung Choi
Jin Seok Yu
Young Bin Hong
Ki Wha Chung
Byung-Ok Choi
Genes & Genomics, 2016, 38 : 659 - 667
[49] Reply: Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease
Fabrizi, Gian Maria
Taioli, Federica
Cavallaro, Tiziana
BRAIN, 2012, 135
[50] The role of PMP22 T118M in Charcot–Marie–Tooth disease remains unsolved
Record, Christopher J.
Laura, Matilde
Rossor, Alexander M.
Reilly, Mary M.
Journal of Biological Chemistry, 2023, 299 (09)

← 1 2 3 4 5 →